4//SEC Filing
Hamel Lawrence G 4
Accession 0001209191-19-009822
CIK 0001427925other
Filed
Feb 12, 7:00 PM ET
Accepted
Feb 13, 5:45 PM ET
Size
8.2 KB
Accession
0001209191-19-009822
Insider Transaction Report
Form 4
Hamel Lawrence G
Chief Development Officer
Transactions
- Award
Common Stock
2019-02-11+50,000→ 74,371 total - Award
Stock Option (Right to Buy)
2019-02-11+100,000→ 100,000 totalExercise: $2.51Exp: 2029-02-11→ Common Stock (100,000 underlying)
Holdings
- 29,795(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]The restricted stock units shall vest in three equal consecutive annual installments on February 11, 2020, February 11, 2021 and February 11, 2022.
- [F3]The shares subject to the option vest as follows: 25% of the shares subject to the option vest on the 12 month anniversary of the Vesting Commencement Date and the remaining shares subject to the option vest on an equal monthly basis over the following 36 months.
Documents
Issuer
ACELRX PHARMACEUTICALS INC
CIK 0001427925
Entity typeother
Related Parties
1- filerCIK 0001511368
Filing Metadata
- Form type
- 4
- Filed
- Feb 12, 7:00 PM ET
- Accepted
- Feb 13, 5:45 PM ET
- Size
- 8.2 KB